Malignant Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. [Phase 2]
Phase 2 trial update of sorafenib tosylate in malignant mesothelioma has completed (status: COMPLETED).
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: SU5416 in Treating Patients With Malignant Mesothelioma [Phase 2]
The clinical trial update reports the completion of a Phase 2 study of SU5416 in patients with malignant mesothelioma, sponsored by the Nati…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung [Phase 2]
Phase 2 trial evaluating erlotinib in patients with malignant mesothelioma of the pleura; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Gefitinib in Treating Patients With Malignant Mesothelioma [Phase 2]
Gefitinib was studied in a Phase 2 trial for malignant mesothelioma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
This document reports the results of a Phase 2 trial of dasatinib in patients with previously treated malignant mesothelioma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [Phase 1]
Phase 1 clinical trial evaluating erlotinib in patients with solid tumors and liver or kidney dysfunction has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer [NA]
This trial evaluated EF5 as a hypoxia marker to detect oxygen levels and vasculature in tumor cells during photodynamic therapy for intraper…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma [Phase 2]
This entry reports that the Phase 2 trial of Vandetanib for inoperable or relapsed malignant mesothelioma has been terminated, with results …
-
CLINICAL_TRIALS research · 2012-08-02Clinical Trial Update: The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma [Phase 2]
Update on a Phase 2 clinical trial of tremelimumab, an anti-CTLA-4 antibody, in malignant mesothelioma, with the current trial status listed…
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma [Phase 2]
Phase 2 study evaluating tremelimumab as monotherapy for malignant mesothelioma is being conducted; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed [Phase 2]
Phase 2 trial evaluating raltitrexed in patients with unresectable malignant mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura [Phase 3]
Phase 3 trial comparing cisplatin with or without raltitrexed in malignant mesothelioma of the pleura has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma [Phase 2]
Open-label Phase II trial evaluating gefitinib (IRESSA) in patients with malignant mesothelioma has been completed. The study assessed the s…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs [Phase 1]
A Phase 1 clinical trial evaluating inhaled doxorubicin for advanced solid tumors affecting the lungs has completed, including patients with…
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma [Phase 2]
Phase 2 study evaluating bevacizumab (Avastin) plus erlotinib (Tarceva) in previously treated malignant mesothelioma. The trial has complete…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluated pemetrexed with cisplatin and vitamin B12 in patients with unresectable malignant mesothelioma of the chest. The s…
-
CLINICAL_TRIALS research · 2011-03-07Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma [Phase 1]
This is a Phase 1 clinical trial update for a vaccine therapy in patients with stage I-IIIA non-small cell lung cancer or stage I-II maligna…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma [Phase 2]
A Phase 2 trial by Roswell Park Cancer Institute evaluating surgery combined with photodynamic therapy for malignant mesothelioma has comple…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma [Phase 2]
This clinical trial update reports a Phase 2 study evaluating cisplatin with either pemetrexed (Alimta) or gemcitabine in a long infusion fo…
-
CLINICAL_TRIALS research · 2009-12-15Clinical Trial Update: Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
Clinical trial update exploring mesothelin and osteopontin as diagnostic markers for malignant mesothelioma and atypical mesothelial hyperpl…
-
CLINICAL_TRIALS research · 2009-08-04Clinical Trial Update: Sorafenib in Previously Treated Malignant Mesothelioma [Phase 2]
A Phase 2 clinical trial evaluating sorafenib in patients with previously treated malignant mesothelioma is described, with the trial status…
-
CLINICAL_TRIALS research · 2009-07-14Clinical Trial Update: Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery [NA]
Clinical trial update on a study of combination chemotherapy with or without surgery and radiation therapy for malignant mesothelioma that c…
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment [Phase 1]
Phase 1 study evaluating the safety and tolerability of CRS-207, a live-attenuated Listeria monocytogenes-based cancer vaccine, in adults wi…
-
CLINICAL_TRIALS trial_result · 2008-05-28Clinical Trial Update: An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma [Phase 2]
Phase 2 efficacy study of oral Milataxel (TL139) for malignant mesothelioma. The document provides trial information but does not report res…
-
CLINICAL_TRIALS trial_result · 2007-10-30Clinical Trial Update: A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma [Phase 2]
Phase II clinical trial evaluating the combination of Glivec (imatinib) and Gemzar (gemcitabine) in unresectable, refractory malignant mesot…